Fungal pathogens and COVID-19

A Singh, A Kaur, A Chowdhary - Current Opinion in Microbiology, 2023 - Elsevier
COVID-19 pandemic highlighted the complications of secondary fungal infections that
occurred globally in severe cases of coronavirus disease managed in the intensive care …

Pathogenicity & virulence of Histoplasma capsulatum - A multifaceted organism adapted to intracellular environments

AF Valdez, DZ Miranda, AJ Guimarães, L Nimrichter… - Virulence, 2022 - Taylor & Francis
Histoplasmosis is a systemic mycosis caused by the thermally dimorphic fungus
Histoplasma capsulatum. Although healthy individuals can develop histoplasmosis, the …

Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV‐2 infection than negative patients and are …

MA De Francesco, L Signorini, S Piva… - Journal of Medical …, 2023 - Wiley Online Library
Patients with viral infections are at higher risk to acquire bacterial and fungal superinfections
associated with a worse prognosis. We explored this critical point in the setting of patients …

Co-infections and superinfections in COVID-19 critically ill patients are associated with CT imaging abnormalities and the worst outcomes

N Brandi, F Ciccarese, C Balacchi, MR Rimondi… - Diagnostics, 2022 - mdpi.com
Background: Bacterial and fungal co-infections and superinfections have a critical role in the
outcome of the COVID-19 patients admitted to the Intensive Care Unit (ICU). Methods: The …

COVID-19-associated fungal infections in Iran: A systematic review

T Nazari, F Sadeghi, A Izadi, S Sameni, S Mahmoudi - PLoS One, 2022 - journals.plos.org
Objectives This systematic review aims to summarize the mycological and clinical features of
COVID-19-associated fungal infections (CAFIs) in Iran. Methods PubMed, Web of Science …

The potential for rapid antigen testing for mucormycosis in the context of COVID-19

CR Thornton - Expert Review of Molecular Diagnostics, 2024 - Taylor & Francis
Introduction Mucormycosis is a highly aggressive angio-invasive disease of humans caused
by Mucorales fungi. Prior to the COVID-19 pandemic, mucormycosis was a rare mycosis …

[HTML][HTML] Risk factors and clinical outcomes of candidemia associated with severe COVID-19

D Dixit, P Jen, TD Maxwell, S Smoke… - Critical care …, 2022 - journals.lww.com
Risk Factors and Clinical Outcomes of Candidemia Associated... : Critical Care Explorations
Risk Factors and Clinical Outcomes of Candidemia Associated With Severe COVID-19 …

COVID-19-associated fungal infections: an urgent need for alternative therapeutic approach?

M Domán, K Bányai - Frontiers in Microbiology, 2022 - frontiersin.org
Secondary fungal infections may complicate the clinical course of patients affected by viral
respiratory diseases, especially those admitted to intensive care unit. Hospitalized COVID …

[HTML][HTML] Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in …

HY Wu, PH Chang, YS Huang, CS Tsai… - Journal of Microbiology …, 2023 - Elsevier
Abstract Coronavirus disease-19 (COVID-19) is an emerging infectious disease caused by
SARS-CoV-2 that has rapidly evolved into a pandemic to cause over 600 million infections …

[HTML][HTML] Invasive respiratory fungal infections in COVID-19 critically ill patients

F Raffaelli, ES Tanzarella, G De Pascale… - Journal of Fungi, 2022 - mdpi.com
Patients with coronavirus disease 19 (COVID-19) admitted to the intensive care unit (ICU)
often develop respiratory fungal infections. The most frequent diseases are the COVID-19 …